Rescue cat’s legacy funds long-term feline heart research

A rescued Sphynx cat once labeled aggressive at a shelter is now the namesake of a new feline health research chair at NC State’s College of Veterinary Medicine. After Vladimir died of hypertrophic cardiomyopathy, or HCM, in 2024, Amos Cader deepened his support for NC State’s feline cardiology work and has now endowed the Vladimir Cader Feline Health Research Distinguished Chair, with veterinary cardiologist Dr. Joshua Stern as the inaugural recipient. The chair adds long-term funding to a broader philanthropic push that has already included research support, a feline early-innovator award, and a research fellow focused on feline cardiology. (cvm.ncsu.edu)

Why it matters: For veterinary professionals, this is more than a memorial story. NC State says the chair is designed to sustain translational research into diseases such as feline HCM, the most common heart disease in cats, at a time when Stern’s lab is also helping lead work on sirolimus therapy for subclinical HCM. FDA conditionally approved Felycin-CA1 in March 2025 for management of ventricular hypertrophy in cats with subclinical HCM, and Stern said the ongoing HALT study has enrolled more than 300 cats across 28 academic and private-practice centers, underscoring how philanthropy, clinical trials, and specialty practice are increasingly intersecting in feline medicine. (cvm.ncsu.edu)

What to watch: Stern said the HALT study is expected to conclude in 2027, making trial progress, publication of effectiveness data, and any move from conditional to full approval key next milestones. (cvm.ncsu.edu)